We identified two genes with a significant gain in correlation with PTEN in breast cancer samples with PTEN mutations (n = 27) compared to samples without PTEN mutations (n = 816), FASLG and IPCEF1 (Table 4, Fig. 9a-b, Additional file 5). This evidence concerns the gene FASLG and breast cancer.